The application of mass spectrometry to leukemia drug discovery.
a Department of Medicine, Division of Hematology and Medical Oncology , Weill Cornell Medicine and The New York Presbyterian Hospital , New York , NY , USA.
Gail J
GJ
Roboz
b Department of Medicine, Division of Hematology/Oncology , Icahn School of Medicine of Mount Sinai , New York , NY , USA.
John
J
Roboz
D000970:Antineoplastic Agents / Q000627:therapeutic use; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology; D013058:Mass Spectrometry / Q000379:methods*
D000970:Antineoplastic Agents
Acute myeloid leukemia; drug development; mass spectrometry; proteomics